Literature DB >> 3909328

Intraabdominal infections: an overview.

R L Nichols.   

Abstract

Intraabdominal infections are serious clinical problems that generally occur secondary to endogenous contamination following the interruption of the continuity of the gastrointestinal tract by trauma, intrinsic diseases, or surgery. Appropriate treatment necessitates early diagnosis, the accomplishment of which most frequently requires a specialized radiologic procedure such as computed tomography, followed by surgical drainage and appropriate parenteral antibiotic therapy. Several agents alone or others in combination appear to be equally efficacious in treating these infections, which usually are due to the aerobic and anaerobic constituents of the gastrointestinal microflora. Adjunctive surgical techniques include peritoneal irrigation, debridement, and repair of the damaged viscera.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3909328     DOI: 10.1093/clinids/7.supplement_4.s709

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  6 in total

1.  Cost efficacy of tazobactam/piperacillin versus imipenem/cilastatin in the treatment of intra-abdominal infection.

Authors:  E S Dietrich; B Schubert; W Ebner; F Daschner
Journal:  Pharmacoeconomics       Date:  2001-01       Impact factor: 4.981

2.  Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis.

Authors:  A O Tzianabos; D L Kasper; R L Cisneros; R S Smith; A B Onderdonk
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

Review 3.  Piperacillin/tazobactam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.

Authors:  H M Bryson; R N Brogden
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

4.  A prospective, multi centre, randomized clinical study to compare the efficacy and safety of Ertapenem 3 days versus Ampicillin-Sulbactam 3 days in the treatment of localized community acquired intra-abdominal infection. (T.E.A. Study: Three days Ertapenem vs three days Ampicillin-sulbactam).

Authors:  Federico Coccolini; Fausto Catena; Luca Ansaloni; Giorgio Ercolani; Salomone Di Saverio; Filippo Gazzotti; Daniel Lazzareschi; Antonio D Pinna
Journal:  BMC Gastroenterol       Date:  2011-04-18       Impact factor: 3.067

5.  Streptococcus pneumoniae serotype 1 capsular polysaccharide induces CD8CD28 regulatory T lymphocytes by TCR crosslinking.

Authors:  Janina Mertens; Mario Fabri; Alessandra Zingarelli; Torsten Kubacki; Sonja Meemboor; Laura Groneck; Jens Seeger; Martina Bessler; Helena Hafke; Margarete Odenthal; Joan G Bieler; Christoph Kalka; Jonathan P Schneck; Hamid Kashkar; Wiltrud M Kalka-Moll
Journal:  PLoS Pathog       Date:  2009-09-25       Impact factor: 6.823

Review 6.  Risk of infection following penetrating abdominal trauma: a selective review.

Authors:  D S Rush; R L Nichols
Journal:  Yale J Biol Med       Date:  1986 Jul-Aug
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.